Sort
11,323 grants matching “glioblastoma”
Focused ultrasound-enabled brain tumor liquid biopsy
$550,519Hong Chen · Washington University · R01 · FY2024 · EB
IMMUNOTHERAPEUTIC TARGETING OF GLIOBLASTOMA WITH ONCOLYTIC VIRUS AND LISTERIA-BASED ANTICANCER VACCINE
$550,491California Northstate University, Llc · · FY2020 · Defense Health Agency
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
$550,450Charles S Cobbs · Swedish Medical Center, First Hill · R01 · FY2016 · CA
Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma
$550,350Balveen Kaur · Augusta University · R01 · FY2025 · NS
Imaging
$550,184Daniel P Barboriak · Duke University · P01 · FY2013 · CA
Targeting Nucleotide Metabolism to Overcome Therapy Resistance in Glioblastoma
$550,119Daniel R Wahl · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Targeting Malignant Reprogramming of Glioblastoma Stem Cells Through Dual Inhibition of S6K1 and BIRC3
$549,937Arnold Etame · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · NS
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses tohirsutinolides
$549,875James K Turkson · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Focused ultrasound-enabled brain tumor liquid biopsy
$549,451Hong Chen · Washington University · R01 · FY2025 · EB
STAG2 mutations and 3D genome organization in glioblastoma multiforme
$549,445Todd A Waldman · Georgetown University · R01 · FY2022 · CA
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia
$549,296Amin Arbabian · Stanford University · R01 · FY2019 · EB
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$549,102Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Core C: Experimental Models
$548,945Michael E. Berens · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Developing new therapeutic strategies for brain metastasis
$548,753Eva Hernando · New York University School Of Medicine · R01 · FY2025 · CA
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
$548,582Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2018 · NS
Role of meningeal lymphatic vasculature in neuroimmune communication development
$548,579Jean-Leon Thomas · Yale University · R01 · FY2024 · NS
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate
$548,510Lawrence D Recht · Stanford University · R01 · FY2017 · CA
Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma
$548,472Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2021 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2018 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2020 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2019 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$548,365Robert L Martuza · Massachusetts General Hospital · R01 · FY2022 · NS
Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma
$548,232Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Core C: Experimental Models
$548,201Michael E. Berens · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA